New York, NY and Southfield, MI October 23, 2007 The Juvenile Diabetes Research Foundation, the world's largest charitable funder of type 1 diabetes research, today announced a partnership with Housey Pharmaceutical Research Laboratories (HPRL) to support the companys studies to identify compounds to promote the regeneration of functional pancreatic beta cells as a potential treatment for type 1 diabetes.
We are thrilled to be partnering with Housey Pharmaceutical Research Laboratories on this important program. This drug discovery research is aimed at identifying small molecule compounds to promote beta cell growth and survival based on the companys proprietary technology," said Patricia Kilian, Ph.D., Therapeutic Program Director for Regeneration research at JDRF. The results from this study may provide a starting point to develop beta cell regeneration therapeutics targeting key scientific pathways, accelerate the pace of drug discovery and development leading to a cure, and have a significant clinical impact on people with diabetes.
We are very enthusiastic about partnering with JDRF on a project of such fundamental significance in clinical medicine, especially for children, said Gerard Housey, M.D., Ph.D., President of HPRL. We are highly confident with the approach that we are taking and are hopeful that it will lead to substantive advances in the field of diabetes treatment. Furthermore, as a result of the JDRFs creative approach to project support as well as its real-world understanding of modern pharmaceutical industry research, we can now move this project forward more rapidly by partnering with them.
HPRL is the latest company to work with JDRF through its innovative Industry Discovery and Development Partnership program. The IDDP enables JDRF to partner with pharmaceutical, biotech, and medical device businesses that are looking to develop drugs, treatments, technologies, and other therapeutics leading to a cure, reversal, or prevention of type 1 diabetes and its complications.
|Contact: Susan Sherman|
Juvenile Diabetes Research Foundation International